Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy

Por Balar, Arjun, Bajorin, Dean F., Milowsky, Matthew I.
Publicado em 2011

Clinical states model for biomarkers in bladder cancer

Por Apolo, Andrea B, Milowsky, Matthew, Bajorin, Dean F.
Publicado em 2009

Novel strategies for treating relapsed/refractory urothelial carcinoma

Por Iyer, Gopa, Milowsky, Matthew I, Bajorin, Dean F
Publicado em 2010

Practical Use of Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer: Summary of Session at the Society of Urologic Oncology Annual Meeting

Por Apolo, Andrea B., Grossman, H. Barton, Bajorin, Dean, Steinberg, Gary, Kamat, Ashish M.
Publicado em 2012

Tracking the Workforce: The American Society of Clinical Oncology Workforce Information System

Por Kirkwood, M. Kelsey, Kosty, Michael P., Bajorin, Dean F., Bruinooge, Suanna S., Goldstein, Michael A.
Publicado em 2013

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

Por Apolo, Andrea B., Riches, Jamie, Schöder, Heiko, Akin, Oguz, Trout, Alisa, Milowsky, Matthew I., Bajorin, Dean F.
Publicado em 2010

CONTEMPORARY LYMPH NODE COUNTS DURING PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION

Por Thompson, R. Houston, Carver, Brett S., Bosl, George J., Bajorin, Dean, Motzer, Robert, Feldman, Darren, Reuter, Victor E., Sheinfeld, Joel
Publicado em 2010

BODY MASS INDEX IS ASSOCIATED WITH HIGHER LYMPH NODE COUNTS DURING RETROPERITONEAL LYMPH NODE DISSECTION

Por Thompson, R. Houston, Carver, Brett S., Bosl, George J., Bajorin, Dean, Motzer, Robert, Feldman, Darren, Reuter, Victor E., Sheinfeld, Joel
Publicado em 2011

EVALUATION OF LYMPH NODE COUNTS IN PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION

Por Thompson, R. Houston, Carver, Brett S., Bosl, George J., Bajorin, Dean, Motzer, Robert, Feldman, Darren, Reuter, Victor E., Sheinfeld, Joel
Publicado em 2010

Who Does Not Receive Treatment for Cancer?

Por Ward, Marcia M., Ullrich, Fred, Matthews, Kevin, Rushton, Gerard, Goldstein, Michael A., Bajorin, Dean F., Hanley, Amy, Lynch, Charles F.
Publicado em 2013

The Total Number of Retroperitoneal Lymph Nodes Resected Impacts Clinical Outcome Following Chemotherapy for Metastatic Testicular Cancer

Por Carver, Brett S., Cronin, Angel M., Eggener, Scott, Savage, Caroline J., Motzer, Robert J., Bajorin, Dean, Bosl, George J., Sheinfeld, Joel
Publicado em 2010

The High Incidence of Vascular Thromboembolic Events in Advanced Urothelial Cancer Treated with Platinum Chemotherapy Agents

Por Tully, Christopher M., Apolo, Andrea B., Zabor, Emily C., Regazzi, Ashley M., Ostrovnaya, Irina, Rosenberg, Jonathan E., Bajorin, Dean F.
Publicado no Cancer (2015)

Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Non-Seminomatous Germ Cell Tumors

Por Kundu, Shilajit D., Feldman, Darren R., Carver, Brett S., Gupta, Amit, Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Sheinfeld, Joel
Publicado no J Urol (2014)

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

Por Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
Publicado no J Urol (2015)

Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors

Por Mano, Roy, Becerra, Maria F., Carver, Brett S., Bosl, George J., Motzer, Robert J., Bajorin, Dean F., Feldman, Darren R., Sheinfeld, Joel
Publicado no J Urol (2016)

Final Results of Sequential Doxorubicin Plus Gemcitabine and Ifosfamide, Paclitaxel, and Cisplatin Chemotherapy in Patients With Metastatic or Locally Advanced Transitional Cell Ca...

Por Milowsky, Matthew I., Nanus, David M., Maluf, Fernando C., Mironov, Svetlana, Shi, Weiji, Iasonos, Alexia, Riches, Jamie, Regazzi, Ashley, Bajorin, Dean F.
Publicado no J Clin Oncol (2009)

Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group

Por Fabian, Carol J., Meyskens, Frank L., Bajorin, Dean F., George, Thomas J., Jeter, Joanne M., Khan, Shakila, Tyne, Courtney A., William, William N.
Publicado no J Clin Oncol (2016)

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy

Por Kaag, Matthew G., Milowsky, Matthew I., Dalbagni, Guido, Thompson, R. Houston, Katz, Darren, Reuter, Victor E., Herr, Harry W., Bajorin, Dean, Bochner, Bernard H.
Publicado no BJU Int (2011)

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

Por Buckley, Michael T, Yoon, Joanne, Yee, Herman, Chiriboga, Luis, Liebes, Leonard, Ara, Gulshan, Qian, Xiaozhong, Bajorin, Dean F, Sun, Tung-Tien, Wu, Xue-Ru, Osman, Iman
Publicado em 2007

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

Por Sharma, Padmanee, Shen, Yu, Wen, Sijin, Yamada, Sachiko, Jungbluth, Achim A., Gnjatic, Sacha, Bajorin, Dean F., Reuter, Victor E., Herr, Harry, Old, Lloyd J., Sato, Eiichi
Publicado em 2007